June 1, 2017 / 5:39 AM / 6 months ago

BRIEF-Adocia launches first-in-man clinical study of BioChaperone Glucagon

June 1 (Reuters) - ADOCIA SA:

* LAUNCHES FIRST-IN-MAN CLINICAL STUDY OF BIOCHAPERONE GLUCAGON

* RESULTS ARE EXPECTED IN Q4 2017

* STUDY WILL DOCUMENT SAFETY AND TOLERABILITY OF BIOCHAPERONE GLUCAGON AS WELL AS ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROFILES IN PEOPLE WITH TYPE 1 DIABETES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below